{"passport":{"unfragile":{"@version":"1.0","version":"2026-05","artifact":{"id":"tool_qureight","slug":"qureight","name":"Qureight","type":"product","url":"https://qureight.com","page_url":"https://unfragile.ai/qureight","categories":["research-search"],"tags":[],"pricing":{"model":"paid","free":false,"starting_price":null},"status":"active","verified":false},"capabilities":[{"id":"tool_qureight__cap_0","uri":"capability://research.clinical.data.pattern.recognition","name":"clinical-data-pattern-recognition","description":"Analyzes large-scale clinical datasets to identify hidden patterns, correlations, and relationships between patient characteristics, biomarkers, and treatment outcomes. Uses machine learning algorithms to surface insights that would be difficult or impossible to detect through traditional statistical analysis.","intents":["I need to understand what patient characteristics predict treatment success","I want to discover unexpected relationships in my clinical data","I need to identify subgroups within my patient population that respond differently to treatment"],"best_for":["large pharmaceutical companies","clinical research organizations","phase II/III trial sponsors"],"limitations":["requires large, high-quality datasets to be effective","algorithm validation methodology not publicly transparent","may identify correlations that don't have causal explanations"],"requires":["structured clinical data","patient outcome data","biomarker measurements","integration with existing data systems"],"input_types":["structured clinical databases","EHR data","biomarker datasets","trial outcome records"],"output_types":["pattern insights","statistical correlations","patient subgroup definitions"],"categories":["research","data-analysis"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_1","uri":"capability://research.patient.cohort.stratification","name":"patient-cohort-stratification","description":"Automatically identifies and segments patient populations into distinct cohorts based on clinical characteristics, biomarkers, and predicted treatment response. Enables precise targeting of specific patient groups for clinical trials or treatment protocols.","intents":["I need to identify which patients are most likely to benefit from this drug","I want to segment my patient population for more targeted trial enrollment","I need to define inclusion/exclusion criteria based on predictive biomarkers"],"best_for":["trial sponsors","pharmaceutical companies","clinical research organizations"],"limitations":["requires sufficient patient data to create meaningful cohorts","cohort definitions may not be easily interpretable","validation against real-world outcomes needed"],"requires":["patient demographic data","clinical measurements","biomarker data","treatment outcome data"],"input_types":["patient records","biomarker panels","clinical measurements","treatment history"],"output_types":["patient cohort definitions","stratification criteria","cohort size estimates","predicted response profiles"],"categories":["research","clinical-trial-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_2","uri":"capability://research.biomarker.identification.and.validation","name":"biomarker-identification-and-validation","description":"Discovers and validates biomarkers that predict patient response to specific treatments or disease progression. Analyzes molecular, genetic, and clinical data to identify measurable indicators that correlate with clinical outcomes.","intents":["I need to find biomarkers that predict which patients will respond to our drug","I want to validate whether a suspected biomarker actually predicts treatment response","I need to identify new biomarkers from our clinical data"],"best_for":["pharmaceutical R&D teams","clinical research organizations","biomarker-driven trial designers"],"limitations":["requires large sample sizes for statistical power","biomarker validation requires prospective confirmation","may identify spurious correlations in small datasets"],"requires":["molecular/genetic data","clinical outcome data","patient samples","treatment response records"],"input_types":["genomic data","proteomic data","clinical measurements","outcome data"],"output_types":["biomarker candidates","validation statistics","predictive models","biomarker panels"],"categories":["research","precision-medicine"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_3","uri":"capability://research.trial.failure.risk.prediction","name":"trial-failure-risk-prediction","description":"Predicts the likelihood of clinical trial failure based on trial design parameters, patient population characteristics, and historical trial data. Helps sponsors identify high-risk trial designs early and optimize protocols before enrollment begins.","intents":["I want to know if my trial design is likely to fail before I invest millions","I need to assess the risk of my phase II/III trial based on similar historical trials","I want to optimize my trial protocol to reduce failure risk"],"best_for":["trial sponsors","pharmaceutical companies","clinical development teams"],"limitations":["predictions based on historical data may not apply to novel therapies","requires access to trial outcome data","cannot account for unforeseen safety issues"],"requires":["trial design parameters","patient population data","historical trial outcomes","therapeutic area data"],"input_types":["trial protocol details","patient demographics","inclusion/exclusion criteria","endpoint definitions"],"output_types":["failure risk scores","risk factors","optimization recommendations","probability estimates"],"categories":["research","clinical-trial-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_4","uri":"capability://research.optimal.patient.population.identification","name":"optimal-patient-population-identification","description":"Determines the ideal patient population for a clinical trial by analyzing which patient characteristics, demographics, and biomarkers are most likely to show treatment efficacy. Optimizes trial design to maximize the probability of success.","intents":["I need to find the right patients for my trial to maximize the chance of success","I want to know which patient subgroup will show the strongest drug effect","I need to define the target population for my drug based on data"],"best_for":["trial sponsors","pharmaceutical companies","clinical development teams"],"limitations":["requires substantial historical data on similar populations","may narrow patient population too much","identified populations must be clinically meaningful"],"requires":["patient outcome data","treatment response data","demographic data","biomarker data"],"input_types":["clinical trial data","patient records","biomarker results","outcome measurements"],"output_types":["target population definitions","inclusion criteria","patient selection algorithms","population size estimates"],"categories":["research","clinical-trial-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_5","uri":"capability://research.time.to.market.acceleration","name":"time-to-market-acceleration","description":"Reduces clinical development timelines by optimizing trial design, patient selection, and protocol efficiency. Enables faster progression through development phases by reducing trial failure rates and improving enrollment efficiency.","intents":["I need to get my drug to market faster","I want to reduce the time spent in clinical development","I need to optimize my trial timeline and reduce delays"],"best_for":["pharmaceutical companies","biotech firms","clinical development teams"],"limitations":["cannot accelerate regulatory review timelines","depends on trial execution quality","requires upfront investment in data analysis"],"requires":["trial design optimization","patient stratification","protocol efficiency improvements","data integration"],"input_types":["trial protocols","patient data","enrollment data","outcome data"],"output_types":["optimized trial designs","timeline projections","efficiency recommendations","enrollment strategies"],"categories":["research","business-optimization"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_6","uri":"capability://research.development.cost.reduction","name":"development-cost-reduction","description":"Lowers clinical development costs by reducing trial failure rates, optimizing patient enrollment, and improving trial efficiency. Enables companies to achieve regulatory approval with fewer failed trials and more efficient resource allocation.","intents":["I need to reduce the cost of developing this drug","I want to avoid expensive trial failures","I need to optimize my R&D budget allocation"],"best_for":["pharmaceutical companies","biotech firms","clinical development teams"],"limitations":["upfront investment required for platform implementation","cost savings depend on trial success","may require changes to existing processes"],"requires":["trial optimization","patient stratification","failure risk reduction","efficiency improvements"],"input_types":["trial data","cost data","outcome data","resource allocation data"],"output_types":["cost projections","savings estimates","optimization recommendations","ROI analyses"],"categories":["research","business-optimization"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_7","uri":"capability://research.clinical.data.system.integration","name":"clinical-data-system-integration","description":"Seamlessly integrates with existing electronic health record (EHR) and clinical data management systems used by pharmaceutical companies and research organizations. Minimizes implementation friction by working with data already in use.","intents":["I want to use AI insights without disrupting my existing data systems","I need to connect this platform to my EHR and clinical databases","I want to minimize the effort required to implement this solution"],"best_for":["large pharmaceutical companies","clinical research organizations","healthcare systems"],"limitations":["requires compatible data formats","integration complexity depends on existing system architecture","data governance and security requirements must be met"],"requires":["existing clinical data systems","data standardization","API access","security infrastructure"],"input_types":["EHR data","clinical databases","data warehouses","trial management systems"],"output_types":["integrated data pipelines","unified patient records","analysis-ready datasets"],"categories":["research","data-integration"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_qureight__cap_8","uri":"capability://research.trial.success.rate.improvement","name":"trial-success-rate-improvement","description":"Increases the probability of clinical trial success through evidence-based patient stratification, optimal cohort selection, and protocol optimization. Demonstrates measurable improvements in phase II/III trial success rates.","intents":["I want to increase the likelihood that my trial will succeed","I need to improve my phase II/III success rates","I want data-driven evidence that my trial design will work"],"best_for":["trial sponsors","pharmaceutical companies","clinical development teams"],"limitations":["success depends on trial execution quality","cannot guarantee success for novel mechanisms","requires quality input data"],"requires":["patient stratification","biomarker identification","protocol optimization","historical trial data"],"input_types":["trial protocols","patient data","biomarker data","historical outcomes"],"output_types":["success probability estimates","optimization recommendations","evidence summaries","protocol improvements"],"categories":["research","clinical-trial-design"],"confidence":0.5,"matches":0,"success_rate":0}],"trust":{"score":44,"verified":false,"data_access_risk":"low","permissions":["structured clinical data","patient outcome data","biomarker measurements","integration with existing data systems","patient demographic data","clinical measurements","biomarker data","treatment outcome data","molecular/genetic data","clinical outcome data"],"failure_modes":["requires large, high-quality datasets to be effective","algorithm validation methodology not publicly transparent","may identify correlations that don't have causal explanations","requires sufficient patient data to create meaningful cohorts","cohort definitions may not be easily interpretable","validation against real-world outcomes needed","requires large sample sizes for statistical power","biomarker validation requires prospective confirmation","may identify spurious correlations in small datasets","predictions based on historical data may not apply to novel therapies","builder identity is not verified yet","no observed match outcomes yet"],"rank_breakdown":{"adoption":0.41666666666666663,"quality":0.79,"ecosystem":0.15000000000000002,"match_graph":0.25,"freshness":0.75,"weights":{"adoption":0.25,"quality":0.25,"ecosystem":0.1,"match_graph":0.35,"freshness":0.05}},"observed_outcomes":{"matches":0,"success_rate":0,"avg_confidence":0,"top_intents":[],"last_matched_at":null},"maintenance":{"status":"active","updated_at":"2026-05-24T12:16:32.438Z","last_scraped_at":"2026-04-05T13:23:42.537Z","last_commit":null},"community":{"stars":null,"forks":null,"weekly_downloads":null,"model_downloads":null,"model_likes":null}},"distribution":{"claim_url":"https://unfragile.ai/submit?claim=qureight","compare_url":"https://unfragile.ai/compare?artifact=qureight"}},"signature":"jOYNV2hOIZIyeUKI5G03x2sIBJ/YybEAQ9DDXk0I51oYoXp2wkQIad8xSv6IAMZp3NVQQ42fGo505U2kKozhAA==","signedAt":"2026-06-20T08:21:33.579Z","signedBy":"unfragile.ai","version":1},"_links":{"self":"https://unfragile.ai/api/v1/passport/qureight","artifact":"https://unfragile.ai/qureight","verify":"https://unfragile.ai/api/v1/verify?slug=qureight","publicKey":"https://unfragile.ai/api/v1/trust-passport-public-key","spec":"https://unfragile.ai/trust","schema":"https://unfragile.ai/schema.json","docs":"https://unfragile.ai/docs"}}